Research Participant Registry Core
11. RECONNECT-Fragile X
Description:
This is clinical trial sponsored by Zynerba Pharmaceuticals to evaluate an investigational topical cannabidiol gel for use in FXS.
Recruiting Info:
Males 3- 23 years with the fragile X full mutation. Participation involves clinic visits. NC & SC residents contact the UNC Team: Caisi.hecht@cidd.unc.edu
|